181 related articles for article (PubMed ID: 28758812)
21. Fidgetin as a potential prognostic biomarker for hepatocellular carcinoma.
Zhou B; Wang J; Gao J; Xie J; Chen Y
Int J Med Sci; 2020; 17(17):2888-2894. PubMed ID: 33162817
[No Abstract] [Full Text] [Related]
22. Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.
Miltiadous O; Sia D; Hoshida Y; Fiel MI; Harrington AN; Thung SN; Tan PS; Dong H; Revill K; Chang CY; Roayaie S; Byrne TJ; Mazzaferro V; Rakela J; Florman S; Schwartz M; Llovet JM
J Hepatol; 2015 Dec; 63(6):1368-77. PubMed ID: 26220754
[TBL] [Abstract][Full Text] [Related]
23. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival.
Kato Y; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
Dig Surg; 2018; 35(2):155-163. PubMed ID: 28787731
[TBL] [Abstract][Full Text] [Related]
25. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.
Kim SH; Ahn S; Park CK
Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):51-9. PubMed ID: 22251470
[TBL] [Abstract][Full Text] [Related]
26. LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
J Surg Res; 2010 Mar; 159(1):538-44. PubMed ID: 19111323
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
Atta IS
Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
[TBL] [Abstract][Full Text] [Related]
28. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
29. Expression of IL-26 predicts prognosis of patients with hepatocellular carcinoma after surgical resection.
Xi ZF; Jeong S; Wang CC; Li HJ; Guo H; Cai J; Li JX; Kong XN; Tong Y; Xia Q
Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):242-248. PubMed ID: 30956053
[TBL] [Abstract][Full Text] [Related]
30. Elevated hepatocyte paraffin 1 and neprilysin expression in hepatocellular carcinoma are correlated with longer survival.
Mondada D; Bosman FT; Fontolliet C; Seelentag WK
Virchows Arch; 2006 Jan; 448(1):35-45. PubMed ID: 16220294
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Implications of Arginase and Cytokeratin 19 Expression in Hepatocellular Carcinoma After Curative Hepatectomy: Correlation With Recurrence-Free Survival.
Obiorah IE; Chahine J; Ko K; Park BU; deGuzman J; Kallakury B
Gastroenterology Res; 2019 Apr; 12(2):78-87. PubMed ID: 31019617
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection.
Zhao RC; Zhou J; Chen KF; Gong J; Liu J; He JY; Guan P; Li B; Qin Y
Neoplasma; 2016; 63(2):288-98. PubMed ID: 26674131
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and Prognostic Value of Plasma CD24 Level in Hepatocellular Carcinoma.
Maimaitiming A; Zhou X; Ma X; Huang Y; Wang Q; Deng R; Ren Y; Chai X; Zhang P
J Invest Surg; 2020 Jul; 33(6):536-541. PubMed ID: 30543135
[No Abstract] [Full Text] [Related]
35. Cytokeratin19 positive hepatocellular carcinoma is associated with increased peritumoral ductular reaction.
Cai X; Feng L; Liu H; Xu M; Qu Y; Wan X; Gao C; Lu L
Ann Hepatol; 2016; 15(3):386-93. PubMed ID: 27049492
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.
Liao M; Tong P; Zhao J; Zhang Y; Li Z; Wang J; Feng X; Hu M; Pan Y
Pathol Oncol Res; 2012 Apr; 18(2):397-403. PubMed ID: 21909684
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Chung GE; Lee JH; Yoon JH; Myung SJ; Lee K; Jang JJ; Lee JM; Kim SH; Suh KS; Kim YJ; Lee HS
Abdom Imaging; 2012 Jun; 37(3):439-46. PubMed ID: 21584634
[TBL] [Abstract][Full Text] [Related]
38. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
39. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
[TBL] [Abstract][Full Text] [Related]
40. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
